Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
NCT00056654
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
164
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasms
Interventions
DRUG:
Leuprolide acetate
Sponsor
Abbott